A Switchable, Dual-Functioning Trojan Horse for Alzheimer’s Disease Photothera

Sir Wilfrid Laurier S.S.

Blood-brain barrier drug delivery problems of existing neuropharmaceuticals can be solved using genetically engineered molecular Trojan horses. A novel tailor-made Trojan horse drug that quickly switches into an aggressive molecule to destroy even the residual amyloid plaques could be more effective than any known drug thus far developed for Alzheimer’s disease.

Biography

Amal is enrolled in the enrichment program at Sir Wilfrid Laurier S.S. She enjoys reading, graphic designing, and playing the viola and piano. Amal has won a few honors/awards from the Gauss Contest, the Canadian Royal Legion Speech Contest, the Thames Valley Science and Engineering Fair, the Canada Wide Science Fair, and the Sanofi Biogenius Competition. In her project, Amal proposes that the blood-brain barrier drug delivery problems of existing neuropharmaceuticals can be solved using genetically engineered molecular Trojan horses. A novel, tailor-made, photoactive, Trojan horse drug that quickly switches into an aggressive molecule to destroy even residual amyloid plaques could be more effective than any other known drug developed for Alzheimer’s disease thus far.